Showing results (1-10 of 330) with videos related to
Sort By:
Pageof 33
Texas Medicine|December 1, 1989
Cholesterol education implications for clinical practiceS M Grundy, D W BilheimerProceedings of the National Academy of Sciences of the United States of America|April 1, 1984
Inhibition of 3-hydroxy-3-methylglutaryl-CoA reductase by mevinolin in familial hypercholesterolemia heterozygotes: effects on cholesterol balanceS M Grundy, D W BilheimerJAMA|November 28, 1986
Normal cholesterol levels with lovastatin (mevinolin) therapy in a child with homozygous familial hypercholesterolemia following liver transplantationC East, S M Grundy, D W BilheimerAnnals of Internal Medicine|July 1, 1988
Combination drug therapy for familial combined hyperlipidemiaC East, D W Bilheimer, S M GrundyMetabolism: Clinical and Experimental|February 1, 1986
Preliminary report: treatment of type 3 hyperlipoproteinemia with mevinolinC A East, S M Grundy, D W BilheimerArteriosclerosis (Dallas, Tex.)|November 1, 1985
Kinetic mechanisms determining variability in low density lipoprotein levels and rise with ageS M Grundy, G L Vega, D W BilheimerAnnals of Internal Medicine|September 1, 1985
Influence of combined therapy with mevinolin and interruption of bile-acid reabsorption on low density lipoproteins in heterozygous familial hypercholesterolemiaS M Grundy, G L Vega, D W BilheimerThe Journal of Clinical Investigation|August 1, 1979
Metabolic studies in familial hypercholesterolemia. Evidence for a gene-dosage effect in vivoD W Bilheimer, N J Stone, S M GrundyMetabolism: Clinical and Experimental|February 1, 1984
The effect of diabetic control on very low-density lipoprotein--triglyceride metabolism in patients with type II diabetes mellitus and marked hypertriglyceridemiaF L Dunn, P Raskin, D W Bilheimer, et al.American Journal of Medical Genetics|November 1, 1985
Clinical studies in a kindred with a kinetic LDL receptor mutation causing familial hypercholesterolemiaD W Bilheimer, C East, S M Grundy, et al.Pageof 33